Emily Pond

Researchers studied the rates of COVID-19 infection and death, and assessed the effect of corticosteroids on outcomes, among patients with rare autoimmune rheumatic diseases.

Researchers assessed the long-term survival rates among patients with psoriasis receiving adalimumab and infliximab.

BRAF V600E molecules were found to be homogenously distributed throughout the tumor and are associated with improved prognosis in SSMs.

Investigators report real-world evidence on the treatment of atopic dermatitis derived from the TARGET-DERM study.

An updated epidemiologic perspective on ocular rosacea is provided.

Investigators assessed the impact of mask wearing on perception of health during the COVID-19 pandemic.